Equipped with magnetic resonance contrast agents, pepstatin A-functionalized liposomes could be used as diagnostic tools in a wide array of cancers overexpressing cathepsin D. Moreover, liposomes could be loaded with a chemotherapeutic agent and thus utilized as a potent drug delivery system. The gene discussed is CTSD; the disease is cancer.